Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease (Q35650273)
Jump to navigation
Jump to search
scientific article published on December 22, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease |
scientific article published on December 22, 2011 |
Statements
1 reference
Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease (English)
1 reference
Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease (English)
1 reference
Geoffrey L. Ray
Kwamena E. Baidoo
Lanea M. M. Keller
Paul S. Albert
Martin W. Brechbiel
Diane E. Milenic
1 December 2011
1 reference
22 December 2011
1 reference
5
1 reference
1
1 reference
1-15
1 reference
22 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference